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Abstract
Introduction: Human cytomegalovirus (HCMV) infection has been implicated in the development of
autoimmunity, including systemic lupus erythematosus (SLE). Previously we reported that HCMV phosphoprotein
65 (pp65) could induce early onset of autoantibody and glomerulonephritis on lupus-prone NZB/W mice. This
study further examined whether the B cell epitope(s) in pp65 is able to drive the development of autoantibody.
Methods: Sera from SLE patients or HCMVpp65-immunized mice were analyzed for anti-nuclear antibody by
immunoblotting, enzyme-linked immunosorbent assay (ELISA), immunofluorescent stain and Crithidia luciliae stain.
The deposition of immunoglobulin to the kidney was also examined by immunofluorescent stain. The interactions
between pp65 sub-fragment to cellular proteins were revealed by yeast two-hybrid analyses.
Results: Our results showed that most SLE patients possessed antibodies to the C-terminal half of the HCMVpp65
antigen. Of these positive sera, 73% were also positive to the pp65336-439 sub-fragment. The immunization of
pp65336-439 induced formation of multiple anti-nuclear antibodies, including anti-chromatin, anti-centriole, anti-
mitotic spindle type I/II (MSA I/II) and a significant elevation of anti-double-stranded DNA (anti-dsDNA) antibodies
on BALB/c mice. Yeast two-hybrid analyses revealed the binding of pp65336-439 sub-fragment to cellular proteins.
Immunoglobulin deposition on glomeruli was also detected on pp65336-439-immunized mice.
Conclusions: Our data suggested that HCMVpp65336-439 sub-fragment may induce cross-reactive antibodies to
several nuclear antigens, which could contribute to the development of autoimmunity in genetic-suspected
individuals.
Introduction
The Epstein-Barr virus (EBV)-infection-induced systemic
lupus erythematosus (SLE)-specific autoantibody is one
of the best examples for cross-reactive antibody mediated
autoimmunity [1]. In those studies, autoantibodies to
Smith antigen B/B’ (SmB/B’) and clinical symptoms that
resemble SLE were induced by normal strains of mice
following immunization of octapeptide (PPPGRRP) [2].
The amino acid sequence is not a reliable indicator to
predict cross-reactivity because antibodies to amino acid
52 to 72 of Epstein-Barr virus nuclear antigen 1 (EBNA-
152-72) also cross-reacted to amino acid 169 to 180 of Ro
antigen (Ro169-180) disregard significant differences of
both sequences [3].
HCMV belongs to the Betaherpesvirinae family and is
an opportunistic pathogen that could cause severe clini-
cal consequences in individuals with impaired immune
systems [4]. Specific activation of both viral-specific and
auto-reactive T-cells during infection has been shown to
accelerate the development of type I diabetes [5,6].
HCMV-infection-induced Ro60 antigen expression on
the cell surface and elevated anti-phospholipid antibody
has been reported [7,8]. In addition, a higher prevalence
of autoantibody to U1 small nuclear ribonucleoprotein
(U1 snRNP) in SLE patients and animals are associated
with HCMV infection or immunization, respectively
[9,10]. The tegument phosphoprotein 65 (pp65, UL83) of
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ion and an immunodominant target to both CD4
+ and
CD8
+ T cells [11,12]. Two T-cell dominant regions,
pp65303-388 and pp65477-561, located on the C-terminus of
pp65, have been reported and at least 28 CTL epitopes
were verified within the CMVpp65 [13,14].
It has been demonstrated that in addition to activating
T-cells, immunization of pp65 encoded plasmid could
induce early onset of autoantibody activity and glomeru-
lonephritis on lupus-prone animals [15]. The anti-pp65
antibody activity is not a common feature of healthy indi-
viduals, only 11.11% normal sera (sera from healthy
donors) possess antibodies to pp65 antigen [15]. Immuni-
zation of pp65 antigen or its fragments in Freund’sa d j u -
vant to BALB/c mice only elicited anti-pp65 activity for a
limited time [15]. The C3d is a degraded peptide of the
third complement complex protein and ligand to com-
plement receptor 2 (CR2/CD21). Because of its CD21
binding property, C3d has been used as an adjuvant to
enhance the immunization efficiency or to activate aner-
gic B cells [16-18]. Here, we reported that immunization
of pp65336-439 w i t hC 3 da sa d j u v a n tt oB A L B / cm i c e
induced diverse nuclear-targeting autoantibodies and
immunoglobulin deposition on glomeruli. Moreover,
pp65336-439 induced immunity cross-reacts to multiple
cellular proteins suggesting that immune responses to
pp65336-439 may instigate autoimmunity.
Materials and methods
Human sera
This study involving human subjects was approved by the
Tzu-Chi University, National Science Committee and the
National Blood Center or Taichung Veteran Hospital
Review Boards and approved by the Committee of Ethics
in Tzu-Chi University [15]. A selected portion of patients’
sera were removed from this study subsequently due to
restriction from Institutional Review Boards. All subjects
in this study gave their informed consents. Patients were
classified based on the classification criteria of the Ameri-
can College of Rheumatology as SLE (n = 61), rheuma-
toid arthritis (RA, n =5 0 ) ,S j ö g r e n ’s syndrome (SS, n =
13) and systemic sclerosis (SSc, n = 20). Normal sera (n =
45) were collected from qualified, sex- and age-matched
adult blood donors.
Mice
Normal six- to eight-week-old female BALB/c mice were
purchased from the National Laboratory Animal Center
(NLAC), Taipei, Taiwan. Animals were housed in a
pathogen-free facility with an independent ventilation
cage system at the Laboratory Animal Center of Tzu-
Chi University, Hualien, Taiwan. All animal experiments
were approved by Tzu-Chi University Animal Experi-
mental Ethics Committee (reference number 94-A-06).
Constructions and expression plasmids
The pp651-167, pp65167-336 and pp65336-561 sequences are
amplified using the following primer pair sequences,
respectively listed in Table 1. The sequences were
designed using the published nucleotide sequence of pp65
(strain: AD-169, GenBank: FJ527563). The fragments of
pp651-167,p p 6 5 167-336, and pp65336-561 were prepared from
PCR and digested by restrictive enzymes, and then ligated
into pET30. The pp65336-379, pp65379-455 and pp65455-561
fragments were digested from pp65336-561 to form 132-bp
(BamHI/HindIII), 231-bp (HindIII/NotI) and 321-bp
(NotI/XhoI) fragments, respectively. The pp65336-422,
pp65336-439 and pp65336-448 encoding sequences were
amplified from a pp65336-561 clone using both upstream
and downstream primers (Table 1). The pp65 sub-frag-
ments mentioned above were cloned and inserted into
pET30. The murine C3d encoding sequence (GenBank:
DQ408205) was PCR amplified with C3d primers and
ligated into pET32 (Table 1). For yeast two-hybrid analy-
sis, PCR product of pp65336-439 was cloned into pAS-1
plasmid to create a pAS-1-pp65336-439-binding domain
(BD) plasmid.
Antigen preparation, biotinylation and streptavidin
conjugation
Recombinant proteins were over-expressed in E. coli with
1m Mi s o p r o p y lb-D-thiogalactoside (IPTG, Sigma-
Aldrich, St. Louis, MO, USA) induction and purified by
nickel affinity column. The C3d biotinylation and strepta-
vidin (SA) conjugation (Pierce, Thermo Scientific, Rock-
ford, IL, USA) were performed by the manufacturers’
instructions. In brief, maleimide-activated streptavidin
(Pierce) was conjugated with proteins containing reduced
disulfide bonds from a disulfide reducing gel (Pierce) and
mixed with biotinylated C3d to form the protein-SA-C3d
tetramer, including pp651-167,p p 6 5 336-439 and SA-C3d
only. Tetramers were generated and prepared for immuni-
zation within four hours.
Immunization and sera collection
A total of 35 six- to eight-week-old female BALB/c mice
were randomly separated into groups of pp651-167-C3d (n
=1 1 ) ,p p 6 5 336-439-C3d (n = 17), SA-C3d (n = 5) and PBS
(n = 2). Mice were inoculated intraperitoneally with 50 μg
pp65336-439-C3d or pp651-167-C3d, or SA-C3d in complete
Freund’s adjuvant (Complete Freund’s Adjuvant, Sigma-
Aldrich) or phosphate-buffered saline (PBS, 3.2 mM
Na2HPO4, 0.5 mM KH2PO4, 1.3 mM KCl, 135 mM NaCl,
pH 7.4). Boosting was performed with antigens in incom-
plete Freund’s adjuvant (Incomplete Freund’s Adjuvant,
Sigma-Aldrich) three times in three weeks. Mice were bled
via the retro-orbital vein one day prior to each assay and at
two-week intervals. Unused sera were stored at -20°C and
the diluted sera for use were kept at 4°C.
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assay
Immunoblotting was performed as previously described
[ 1 5 ] .I nb r i e f ,1×1 0
8 cultured HeLa cells or 2 μgp u r i -
fied HCMV were prepared, homogenized and separated
by 12% sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE/slab gel format). Separated pro-
teins were transferred to nitrocellulose paper and
blocked by 5% skim milk then analyzed with mice or
human sera at dilutions of 1:500 or 1:1,000 in PBS. The
antibody reactivity was detected by horseradish peroxi-
dase (HRP) conjugated secondary antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA)
and chemiluminescent detection agents (Perkin Elmer,
Norwalk, CT, USA).
ELISA was performed as previously described [15]. In
brief, for the anti-dsDNA antibody assay, 1 μg/well of
purified calf thymus dsDNA (Sigma-Aldrich) in ddH2O
was coated to a microtiter plate (Corning, Lowell, MA,
USA). After blocking with 5% skim milk, mice or human
sera at 1:100 and 1:1,000 dilutions in PBS, respectively,
were added and incubated at room temperature (RT) for
two hours. At the end of incubation, the plate was
washed and bound antibodies were detected by HRP con-
jugated secondary antibodies at dilutions of 1:10,000 (for
anti-dsDNA IgG) or 1:2,000 (for anti-dsDNA IgG sub-
types, Bethyl Laboratories, Montgomery, TX, USA, puri-
fied HCMV or 1 μg/well of HeLa lysate in PBS were
coated on a microtiter plate at 4°C overnight [15]. After
the plate was skim-milk-blocked, mouse or human sera
were added at dilutions of 1:500 or 1:1,000, respectively,
in PBS and incubated at 4°C for two hours. The bound
antibodies were detected by a secondary antibody at dilu-
tions of 1:10,000 at 4°C for two hours. The o-phenylene-
diamine dihydrochloride (OPD, Sigma-Aldrich) was used
as the substrate and HRP activity was read at 450 nm
with a micro-ELISA reader (DYNEX MRX II).
For the detection of protein-to-protein interaction
between pp65336-439 and HeLa proteins, whole HeLa
extract (1 × 10
8 cultured HeLa cells) was separated by
12% SDS-PAGE/slab-gel and transferred onto nitrocellu-
lose paper. Before the experiment, the blot was cut into
strips, skim-milk-blocked and then incubated with either
pp65336-439 or pp651-167 His-tag fusion protein at con-
centrations of 20, 10, 5, 2.5, 1.25, 0.625 mg/ml or at
concentrations of 20, 10, 5, 2.5 mg/ml, respectively for
one hour. The pp65336-439 or pp651-167 bound HeLa
proteins were detected by 10,000X diluted HRP-conju-
gated mouse anti-His tag IgG (Serotec, Raleigh, NC,
USA) after one hour of incubation. The reactions were
visualized by chemiluminescent detection agents.
Immunofluorescence
Mouse sera were tested for anti-nuclear antibodies
(ANAs) at a dilution of 1:100 in PBS by a standard anti-
nuclear antibody (ANA) test (Binding site). The reactivity
of anti-dsDNA antibody was tested by immunofluorescent
stain using the Crithidia luciliae test (binding site) with
mice sera at a dilution of 1:40 in PBS, as suggested by the
manufacturer. In brief, 25 μl of diluted mice sera were
incubated with slide-coated HEp-2 or Crithidia luciliae
for 20 minutes in humid chamber at RT. HEp-2 or Crithi-
dia luciliae slides were washed three times in PBS at RT
for 10 minutes each. The bound antibodies were detected
by 100X diluted Fluorescein isothiocyanate (FITC)-conju-
gated anti-mouse IgG (Jackson ImmunoResearch Labora-
tories) for 20 minutes in a humid chamber at RT in the
dark. For nuclear visualization, HEp-2 slide was incubated
in 25 μl of DAPI (0.5 μl/ml, Sigma-Aldrich) at RT for two
minutes in the dark. At the end of staining, slides were
washed (PBS) and mounted (mounting medium) for inves-
tigation by Nikon E800 fluorescence microscopy (Nikon,
Tokyo, JP).
For an immunofluorescent stain on glomerulus, kidneys
were removed from mice, immediately placed in the OCT
gel and frozen at -80°C for 24 hours. The 5-mm-thick fro-
zen sections were stained with FITC-conjugated anti-
mouse IgG at a 1:100 dilution in PBS for 20 minutes in a
humid chamber at RT in the dark. After PBS washing,
coverslips with mounting medium on tissue slides were
Table 1 Primers sets for the truncation of HCMVpp65 antigen constructions
Clones Sequences Vectors
Forward (5- > 3) Reverse (5- > 3)
pp651-167 ATG GAT CCA TGG AGT CGC GCG GTC GCC G CCG GAA TTC CAG TCC CGA GAC CGT GAG GAC CGT pET30
pp65167-336 CGC GGA TCC TGG ACG CGT CAG CAG ACC CA CGC GGA TCC CTC GCG TAT GGC TTG TAC CT pET30
pp65336-561 CGC GGA TCC ACC GTG GAA CTG CGT CAG TA TAG GAT CCA CCT CGG TGC TTT TTG GGC G pET30
pp65336-448 CGC GGA TCC ACC GTG GAA CTG CGT CAG TA CGC CTC GAG CGA CGT GCA CGC CGT CGC pET30
pp65336-439 CGC GGA TCC ACC GTG GAA CTG CGT CAG TA CGC CTC GAG TGA TTT GCG TTT GCG GCC pET30
pp65336-422 CGC GGA TCC ACC GTG GAA CTG CGT CAG TA CGC CTC GAG GCC GGTGAC GCG GGG CGT pET30
murine C3d CGC GAT ATC ACC CCC GCA GGC TGT GGG GAA C 3’ CGC GGA TCC GGA TCC GCT ACG GCT GGG GAG pET32
pp65336-439 CGC GGA TCC ACC GTG GAA CTG CGT CAG TA CGC CTC GAG TGA TTT GCG TTT GCG GCC pAS-1
The underlined sequences mean the usage of restrictive enzyme
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microscopy.
Antibody purification
Moderated Cyanogen bromide (CnBr) powder (Sigma-
Aldrich) was activated as described by the manufacturer.
In brief, purified and sonicator-homogenized HCMV vir-
ions were dissolved in a coupling buffer (0.1 M NaHCO3,
0.5 M NaCl, pH 8.3) with activated CnBr gel at 4°C over-
night. The free active groups on CnBr were deactivated by
0.1 M Tris-HCl (pH 8.0) at RT for two hours. After deacti-
vation, CnBr gel was washed with alternating buffer (0.1 M
NaAc, 0.5 M NaCl, pH 4.0 and 0.1 M Tris-HCl, 0.5 M
NaCl, pH 8.0) twice and washed with 10 ml PBS once. For
purification, 200 μlo fp o o l e dp p 6 5 336-439 or pp651-167
mouse sera in 10 ml PBS were added to HCMV-CnBr gel
and rolled at 4°C overnight. The unbound portion of sera,
flow through, was collected and concentrated as a negative
control, while bound antibodies were eluted by 1 ml of
0.1 M glycine (pH 2.0) [19]. The eluted samples were neu-
tralized immediately with a 30 μl of neutralizing buffer
(1 M Tris-HCl, 2 M NaCl, pH 8.8).
Yeast two-hybrid screening
The Matchmaker yeast two-hybrid screening system
(Clontech. Mountain View, CA, USA) was used to identify
the proteins that were able to interact with pp65336-439
peptide. In this system, yeast two-hybrid library screening
using yeast mating was performed as modified from the
manufacturer’s manual. The DNA fragment encoding
pp65336-439 was cloned into the Gal4BD (DNA-binding
domain of the transcription factor Gal4) vector pGBT-7
and the resulting plasmid was designated as BD-pp65336-
439. The BD-pp65336-439 plasmid was transformed into the
yeast strain AH109 (MATa) for screening the yeast library
strain (Clontech Co.), which is the yeast strain Y187
(Mata) transformed with the AD-cDNA plasmid, HeLa
cDNA cloned into the AD (activation domain of Gal4)
vector pGAD-T7. The AH109 cells bearing BD-pp65336-
439 were cultured in the synthetic dextrose medium lack-
ing tryptophan at 30°C until O.D.600 was approximately
0.8. The AH109 cells bearing BD-pp65336-439 were then
collected and mated with the yeast library strain in 2X
YPDA medium (1% Bacto yeast extract, 2% Bacto peptone,
2% Dextrose, 4% Adenine hemisulfate) at 30°C. After mat-
ing, cells were screened on the synthetic dextrose solid
medium lacking leucine, tryptophan and histidine (SD/-
L/-W/-H) to assay expression of reporter gene HIS3 at 30°
C. The screened colonies were further screened on the
synthetic dextrose solid medium lacking leucine, trypto-
phan, histidine and adenine (SD/-L/-W/-H/-A) to assay
expression of reporter genes HIS3 and ADE2 at 30°C. The
AD-cDNA plasmid was isolated from the screened colony
grown on the SD/-L/-W/-H/-A solid medium and
transformed into E. coli for amplification. To further con-
firm the interaction between pp65336-439 peptide and the
cDNA-encoding protein, both BD-pp65336-439 plasmid and
the purified AD-cDNA plasmid were transformed into
yeast strain YRG2 (Stratagene, La Jolla, CA, USA) and
tested on the SD/-L/-W/-H solid medium containing 15
mM 3-aminotriazole to assay for the expression of the
reporter gene HIS3 at 30°C. The purified AD-cDNA plas-
mid was then sequenced after confirmation.
Statistical analysis
Statistical methodology for differences of titer and pre-
valence in test results was analyzed by GraphPad Prism
(GraphPad Software Inc. La Jolla, CA, USA) and using
the Student t-test and Fisher’s two-tailed exact test,
respectively. Results with a P-value of < 0.05 were con-
sidered to be significant.
Results
The pp65336-439 sub-fragment of HCMV contains a B cell
epitope(s) targeted by IgG from SLE patients
To verify the existence of B-cell epitope(s), HCMVpp65
tegument protein (pp65) was cloned, truncated and
expressed as his-tagged fragments (pp651-167,p p 6 5 167-336
and pp65336-561) that covered the entire antigen (Figure
1). Results showed that HCMV-seropositive SLE patients
responded strongly to pp65336-561 (61%, 37/61) compared
to pp651-167 (7%, 4/61) or pp65167-336 (20%, 12/61). The
elevated positive rate to pp65336-561 by SLE patients’ sera
was not found on either healthy or other disease controls
(Table 2). In order to reveal the dominant epitope(s)
within pp65336-561,p p 6 5 336-561 was sub-cloned into three
fragments, expressed and re-screened (Figure 1). Of the
original 37 pp65336-561-positive sera, 7 were removed
from subsequent tests due to various availability issues.
Of the rest of the 30 pp65336-561-positive sera, 22 were
positive to pp65379-455 (73%, 22/30), 3 were positive to
pp65455-561 (10%, 3/30) and 0 was positive to pp65336-379
(Table 2). Subsequently, pp65336-448,p p 6 5 336-439 and
pp65336-422 fragments were created by partial deletion
from the C-terminus of pp65336-561 (Figure 1). Of 22
pp65379-455-positive sera, 17 were positive to pp65336-448
(77%, 17/22), 16 were positive to pp65336-439 (73%, 16/22)
and 9 were positive to pp65336-422 (41%, 9/22). The sero-
reactivity to three fragments (pp65336-422, pp65336-439 or
pp65336-448) by pp65379-455 positive sera was listed in
Table 3.
Induction of anti-HCMV antibody and anti-HeLa protein
antibody
Although pp65 antigen immunized BALB/c animals pos-
sessed anti-pp65 antibodies and enhanced autoantibody
activities, the titers were reduced in a few weeks after
immunization [15]. To improve the immunogenicity of
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results showed that pp65336-439-immunized mice gradu-
ally increased developed anti-HCMVpp65 IgG reactivity
started at four weeks and continued to the end of the
experiment (12 weeks post-immunization, Figure 2a, b).
In contrast, the titer of anti-HCMVpp65 IgG was signifi-
cantly less for pp651-167-immunized mice (Figure 2a).
The anti-HCMVpp65 IgG was not detected from either
SA-C3d or PBS challenged mice (Figure 2b). Quasi-
quantitative analysis showed that the titers of anti-
HCMVpp65 IgG from pp65336-439 immunization was
t w i c ea sm u c ha ss e r af r o me i t h e rp p 6 5 1-167 (pp65336-439
vs. pp651-167, 0.78 ± 0.02 vs. 0.44 ± 0.05, P < 0.0001) or
SA-C3d (pp65336-439 vs. pp651-167, 0.78 ± 0.02 vs. 0.43 ±
0.02, P < 0.0001) immunized animals at eight weeks
post-immunization (Figure 2a). The IgG reactivity to
HCMV of pp651-167 and SA-C3d was statistically
insignificant.
Figure 1 Schematic representation of truncated HCMVpp65 His-tag fusion proteins (Swiss-Prot: P06725). The full-length of HCMVpp65 is
given in the top figure. Below that, six pp65 sub-fragments, pp651-167, pp65167-336, pp65336-561, pp65336-379, pp65379-455, pp65455-561, and four C
terminal truncated peptides, pp65336-422, pp65336-439, pp65336-448, pp65336-455, are shown. The name of the plasmids which encoded pp65 sub-
fragment proteins are given at the right. HCMVpp65, human cytomegalovirus phosphoprotein 65 (65 kD).
Table 2 The prevalence of antibody to HCMVpp65 sub-fragments in patients with autoimmunity and healthy controls
Antigens SLE SSc SS RA Normal
Age (years) 11 to 77 48 to 79 14 to 79 21 to 81 31 to 73
Mean (years) 33.8 61.9 53.4 54.6 63.2
Total specimen 61 20 13 50 45
Female (%) 93.4 95 92.3 80 57.8
Responsiveness pp651 to 167 (%) 4/61 (7) 3/20 (15) 5/13 (38) 0/50 (0) 6/45 (13)
pp65167 to 336 (%) 12/61 (20) 5/20 (25) 3/13 (23) 16/50 (32) 9/45 (20)
pp65336 to 561 (%) 37/61 (61) 4/20 (20) 2/13 (15) 7/50 (14) 2/45 (4)
pp65336 to 379 (%) 0/30 (0)
pp65379 to 455 (%) 22/30 (73)
pp65455 to 561 (%) 3/30 (10)
pp65336 to 448 (%) 17/22 (77)
pp65336 to 439 (%) 16/22 (73)
pp65336 to 422 (%) 9/22 (41)
RA, rheumatoid arthritis; SS, Sjögren’s syndrome; SSc, systemic sclerosis. For immunoblot and ELISA assay, detection of anti-pp65 sub-fragments antibody was
tested with purified human cytomegalovirus (HCMV) virions, as described in materials and methods. The HCMV positivity is defined by mean + 3 s.e.m of normal
control. The results are representative of triplicated experiments.
Hsieh et al. Arthritis Research & Therapy 2011, 13:R162
http://arthritis-research.com/content/13/5/R162
Page 5 of 15In order to demonstrate that the immunization of
pp65336-439 could lead to the development of cross-reac-
tive autoantibodies, total HeLa lysate was prepared as
the substrate for the detection of anti-HeLa antibodies
(Figure 2c). Although immunization of pp65336-439 and
pp651-167 induced anti-HeLa IgG at 4 weeks and contin-
ued to 12 weeks post-immunization, pp65336-439 immu-
nization exhibited significantly higher anti-HeLa IgG
activity than pp651-167 immunization (pp65336-439 vs.
pp651-167,0 . 5 0±0 . 0 3v s .0 . 3 8±0 . 0 2 ,P = 0.0191) at 8
weeks post-immunization. To exclude the possibility of
HCMV contamination, HeLa lysate were immunoblotted
by pp65 sub-fragment immunized sera (Figure 2d). The
results showed that of eight anti-pp65 positive sera, only
one strongly and another weakly react to HeLa antigens
at 65 kD position.
Induction of anti-nuclear antibody (ANA) by pp65336-439-
immunization
To determine if pp65336-439 immunization could induce
antibodies against nuclear components from HeLa cells,
the anti-nuclear antibody (ANA) test was performed. The
results showed that pp65336-439 immunization induced
multiple ANA staining patterns, including speckled (5/17,
Figure 3a, i), nucleosome (4/17, Figure 3b, j), chromatin
(4/17, Figure 3c, k), mitotic spindle type I (MSA I, 4/17,
Figure 3d, l), mitotic spindle type II (MSA II, 10/17, Figure
3e, m) centriole (6/17, Figure 3f, n) and nucleolar (14/17,
Figure 3g, o) stains at 1:100 dilution at 8 weeks and con-
tinued to 12 weeks post-immunization. In several occa-
sions, ANA patterns were detected at dilution as much as
500-fold. Nuclear stains, however, were not detected from
either SA-C3d or PBS-immunized animals (0/5, 0/2, Fig-
ure 3h, p). Four pp651-167-immunized mice developed
weak anti-nucleolar reactivity (4/11, Figure 3g, o) detect-
able at 1:40 dilution. Taken together, pp65336-439 immuni-
zation could induce cross-reactive antibodies to multiple
nucleus components (Table 4).
Induction of anti-dsDNA antibody by pp65336-439
immunization
Anti-dsDNA antibody is a feature and a disease indicator
for SLE patients [20-22]. ELISA assays showed that
pp65336-439-immunized sera exhibited significantly
enhanced anti-dsDNA antibody activity compared to ani-
mals immunized with pp651-167 (pp65336-439 vs. pp651-
167, 0.66 ± 0.02 vs. 0.48 ± 0.03, P < 0.0001), or SA-C3d
(pp65336-439 vs. SA-C3d, 0.66 ± 0.02 vs.0.42 ± 0.02, P <
0.0001) at 8 weeks and continued to 12 weeks post-
immunization (Figure 4a). The differences of anti-dsDNA
antibody between pp651-167 a n dS A - C 3 di m m u n i z e d
mice were insignificant. The IgG2a to dsDNA is the
dominant isotype to SLE nephritis [23]. ELISA-based
assays showed that 13 of 17 pp65336-439 immunized mice
were positive to dsDNA. Isotyping showed that enhanced
IgG1 (dsDNA (+) IgG1 vs. dsDNA (-) IgG1, 0.50 ± 0.02
vs. 0.35 ± 0.03, P = 0.0029) and IgG2a isotypes (dsDNA
(+) IgG2a vs. dsDNA (-) IgG2a, 0.33 ± 0.02 vs. 0.22 ±
0.02, P = 0.0134) were the contributors of anti-dsDNA
activity (Figure 4b). To confirm the ELISA-based anti-
dsDNA analysis, the Crithidia luciliae stains were per-
formed. Of 17 pp65336-439-immunized animals, 11 were
positive for anti-dsDNA antibody (1:40 dilution) at 8
weeks and continued to 12 weeks post-immunization,
compared to 2 of 11 pp651-167-immunized mice (Figure
4c). All Crithidia luciliae- p o s i t i v es e r aw e r ep o s i t i v ea t
ELISA tests. Only one pp651-167-immunized mouse was
positive for Crithidia luciliae at 12 weeks post-immuni-
zation (Figure 4d).
The elevated anti-HCMV pp65336-439 antibody is cross-
reactive to dsDNA and nucleus components
To elucidate the relation between pp65336-439 immuniza-
tion and anti-nuclear antibody found in animals, antibo-
dies to either pp65336-439 or pp651-167 were affinity
purified from pooled pp65336-439 or pp651-167 immunized
mouse sera. The results showed that affinity-purified
pp65336-439-specific IgG exhibiting significantly enhanced
anti-HCMV activity compare to pp651-167 specific IgG
(pp65336-439 vs. pp651-167, 1.08 ± 0.05 vs. 0.27 ± 0.01, P <
0.0001, Figure 5a). Unbound fractions (flow through) from
purification processes remain anti-HCMV positive, but the
titer reduced significantly (pp65336-439 vs. flow through,
1.08 ± 0.05 vs. 0.41 ± 0.02, P = 0.0003, Figure 5a, b). As
immunofluorescent stains performed in Figure 3, affinity-
purified anti-pp65336-439 antibodies reproduced all ANA
stains found in direct serum-staining (Figure 3), including
speckled (Figure 5c1,c7), chromatin (Figure 5c2,c8), cen-
triole (Figure 5c3,c9) or MSA II (Figure 5c4,c10) stains.
Antibodies purified from flow through or anti-pp651-167
immunized sera, however, did not produce noticeable
nuclear staining patterns (Figure 5c5,c11 and Figure 5c6,
Table 3 The sero-reactivity to pp65 sub-fragments by
pp65379-455 positive sera
Sero-reactivity to antigens Patient number
pp65336-422 pp65336-439 pp65336-448 n =2 2
+++ 1, 4, 5, 9, 13, 17, 18, 19, 22
-++ 7, 10, 11, 12, 14, 16, 20
+-+
++-
--+ 21
-+-
+--
--- 2, 3, 6, 8, 15
+, positive; -, negative
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Page 6 of 15Figure 2 Detection of anti-HCMVpp65 antibody by ELISA and immunoblot assay in immunized BALB/c mice. The IgG against HCMVpp65
or HeLa extract from pp651-167 (n = 11), pp65336-439 (n = 17), SA-C3d (n = 5) or PBS (n = 2) immunized mice. (a) ELISA assays for anti-HCMV
reactivity against purified HCMV virions. Sera were 500X diluted and positivity was defined by mean + 3 s.e.m. of SA-C3d-immunized sera. O.D.450
> 0.50 was considered to be positive. (b) Immunoblot analysis on anti-HCMV reactivity against purified HCMV virions. Sera were 500X diluted.
Top panel: pp651-167 (n = 5), pp65336-439 (n = 5) and PBS (n = 2). Lane 1 to 2 and 3 to 4, PBS-immunized sera at 8 and 12 weeks, lane 5 to 9 and
15 to 19, pp65 to 1-167-immunized sera, lane 10 to 14 and 20 to 24, pp65336-439-immunized sera, lane 25, N: 1,000X diluted healthy control serum,
lane 26, P: 1,000X diluted SLE patient’s serum. Bottom panel: SA-C3d (n = 5), pp651-167 (n = 6) and pp65336-439 (n = 12). Lane 1 to 5, SA-C3d-
immunized sera, lane 6, N: 1,000X diluted healthy control serum, lane 7 to 8, P: 1,000X diluted SLE patients’ sera, lane 9 to 14, pp651-167-
immunized sera, lane 15 to 26, pp65336-439-immunized sera. (c) ELISA assays for anti-HeLa reactivity against total HeLa lysate. Sera were 500X
diluted. O.D.450 > 0.48 was considered to be positive. (d) Immunoblot analysis with mouse sera at eight weeks post-immunization against HCMV
and total HeLa lysate. Top panel: purified HCMV virion blot. Bottom panel: total HeLa lysate blot. Lane1 to 4, C3d-immunized sera, lane 5 to 8,
pp651-167-immunized sera, lane 9 to 12, pp65167-336-immunized sera, lane 13 to 16, pp65336-439-immunized sera. Molecular mass markers (kD) are
shown on the left. MW: molecular weight. w: weeks of post-immunization. Graphs depict mean ± s.e.m. values. Unpaired Student t test was
performed. Results with a P-value of < 0.05 were considered to be significant. These results are representative of triplicated experiments.
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Page 7 of 15c12). In addition to nuclear stain, affinity-purified anti-
pp65336-439 antibody also possessed reactivity to dsDNA as
ELISA and Crithidia luciliae slides demonstrated (0.49 ±
0.02, Figure 6a, b). The difference of anti-dsDNA activity
between purified anti-pp651-167 antibody and flow through
were insignificant (pp651-167 vs. flow through, 0.12 ± 0.01
vs. 0.15 ± 0.01).
Deposition of immunoglobulin or immune complexes
on glomeruli is a characteristic of early nephritis and is
often found in SLE patients [24]. Immunofluorescent
stains with anti-mouse IgG in renal section showed that
pp65336-439-immunized mice developed signs of deposi-
tion of immune complex on glomeruli (Figure 6c1). A
total of 6 of 17 pp65336-439-immunized mice showed
I g Gd e p o s i t i o no ng l o m e r u l i ,b u ts u c hs t a i n sw e r en o t
found in pp651-167 (0/11, Figure 6c2), SA-C3d (0/5, Fig-
ure 6c3) or PBS (0/2, Figure 6c4) treated animals. We
did not observe clinical symptoms, such as proteinuria
or lesions on the kidneys of immunofluorescent-positive
mice. Nevertheless, it is noteworthy that the levels of
immunoglobulin deposition showed positive correlation
to the titers of the anti-dsDNA antibody (data not
shown).
Figure 3 Detection of anti-nuclear reactivity in pp651-167, pp65336-439, SA-C3d or PBS immunized sera. HEp-2 substrate slides were used
for detection of anti-nuclear antibodies. Sera from eight weeks post-immunization were 100X diluted for ANA stains. Patterns of speckle (a, i),
chromatin (b, j), nucleosome (c, k), MSA I (d, l), MSA II (e, m) and centriole (f, n) were revealed with sera from pp65336-439-immunized mice.
Nucleolar response (g, o) was detected in sera from pp651-167 or pp65336-439 immunized mice. Nuclear reactivity was not found in SA-C3d or PBS
immunized mice (h, p). White arrowheads indicate the pattern of nuclear responses. MSA I/II: mitotic spindle type I/II.
Table 4 The summary of ANA patterns in mice against to
cellular components
Nuclear patterns pp651-167
n =1 1
pp65336-439
n =1 7
SA-C3d
n =5
PBS
n =2
Speckle 0 5 0 0
Nucleosome 0 4 0 0
Chromatin 0 4 0 0
Centriole 0 6 0 0
MSA I 0 4 0 0
MSA II 0 10 0 0
Nucleolar 4 14 0 0
MSA I, mitotic spindle type I, MSA II, mitotic spindle type II
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Page 8 of 15Yeast two-hybrid showed the binding of HCMVpp65336-
439 binds to diverse HeLa proteins
Immediately after infection, HCMVpp65 was trans-
ported into the nucleus and migrated to nucleolus [25].
We hypothesized that the pp65336-439 fragment may
complex to intracellular antigens during infection.
Immunoblotting and yeast two-hybrid verified this
hypothesis and showed the association between HeLa
proteins and pp65336-439 (Figure 7, Table 5). Such bind-
ing was not found on either pp651-167 or protein-free
tests. Among those pp65336-439 binding colonies from
yeast two-hybrid, 10 were verified as nucleic acid bind-
ing proteins, heat-shock proteins and apoptosis-related
proteins (Table 5).
Discussion
HCMVpp65 is a strong T-cell antigen to most human
and several epitopes within this antigen have been
mapped from normal population [14,26]. Up to now, 28
CTL epitopes have been reported for pp65 and four of
them are located within pp65336-439 [14]. The elevation
of anti-pp65 antibody is not a rare phenomenon to
Figure 4 Detection of anti-dsDNA antibody in pp651-167, pp65336-439,S A - C 3 do rP B Si m m u n i z e ds e r a .( a) ELISA assays for anti-dsDNA
activity at 1:100 serum dilution. The dsDNA positivity is defined by mean + 3 s.e.m. of SA-C3d-immunized sera. O.D.450 > 0.49 was considered to
be positive. (b) Isotyping of anti-dsDNA antibody for pp65336-439-immunized mice (n = 17) at eight weeks post-immunization. Tests were
performed on ELISA at 1:100 dilution. dsDNA(+): dsDNA seropositive, dsDNA(-): dsDNA seronegative. Graphs depict mean ± s.e.m. values.
Unpaired Student t test was performed. Results with a P-value of < 0.05 were considered to be significant. (c) Representations of Crithidia luciliae
stain by sera from (c1) pp65336-439,( c2) pp651-167,( c3) SA-C3d or (c4) PBS immunized animals at eight weeks post-immunization at 1:40 dilution.
White arrowheads indicate dsDNA positive stains. (d) The summarized results of ELISA assays and Crithidia luciliae stains. These results are
representative of triplicated experiments.
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Page 9 of 15Figure 5 Detection of anti-nuclear reactivity in pp651-167 or pp65336-439 specific antibodies from eight weeks post-immunization sera.
(a) ELISA assays of affinity purified anti-pp65336-439 antibody (pp65336-439), anti-pp651-167 antibody (pp651-167), SLE patients’ sera (SLE) and flow
through against purified HCMV virions. Graphs depict mean ± s.e.m. values. Unpaired Student t test was performed. Results with a P-value of <
0.05 were considered to be significant. (b) Immunoblot assays on affinity purified anti-pp65336-439 antibody (pp65336-439), anti-pp651-167 antibody
(pp651-167), SLE patients’ sera (SLE) and flow through against purified HCMV virions. Molecular mass markers (kD) are shown on the left. MW:
molecular weight. (c) ANA stains with HEp-2 substrate slides were performed with HCMV affinity-purified antibody. Patterns of speckle (c1,c 7),
chromatin (c2,c 8), centriole (c3,c 9) and MSA II (c4,c 10) were revealed with affinity purified anti-pp65336-439 antibodies. Nuclear pattern was not
found in flow through (c5,c 11) or affinity-purified anti-pp651-167 antibody (c6,c 12) stains. White arrowheads indicate the patterns of nuclear
response. MSA II: mitotic spindle type II.
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Page 10 of 15persons during primary HCMV infection or reactivation,
but such activity is rarely sustained [27]. In this study,
we reported at least one SLE-specific, autoimmune-
prone B-cell epitope within HCMVpp65336-439.B - c e l l
epitope(s) within this region may not be unique to SLE
sera, since our mapping has not ruled out the possible
existence of epitope(s) within the junctions of fragments
or conformational epitope(s). Elevated and sustained
anti-pp65 antibody in SLE patients and induction of
autoimmunity via immunization in both of BALB/c and
NZB/W mice suggesting a hypothesis that humoral
immunity toward pp65 antigen may possess a patho-
genic potential [15].
Transient immunity to pp65 can be detected in the
sera of BALB/c mice immunized with either full-length
pp65 or pp65336-439 in Freund’s adjuvant [15]. To study
the effect of anti-pp65 antibody, we have immunized
BALB/c mice with either full-length or truncated pp65
Figure 6 The cross-reactivity of purified anti-pp65336-439 or anti-pp651-167 antibody to dsDNA. (a) ELISA assays for affinity-purified anti-
pp65336-439 antibody (pp65336-439), anti-pp651-167 antibody (pp651-167), flow through and SLE patients’ sera (SLE) against dsDNA. Graphs depict
mean ± s.e.m. values. Unpaired Student t test was performed. Results with a P-value of < 0.05 were considered to be significant. (b)
Representations of Crithidia luciliae stain by affinity-purified anti-pp65336-439 antibody (b1, pp65336-439), anti-pp651-167 antibody (b2, pp651-167), flow
through (b3) and SLE patients’ sera (b4, SLE) against dsDNA. White arrowheads indicate the positive stains. (c) Representations of
Immunofluorescent stain for immunoglobulin deposition on glomerular by pp65336-439 (c1) immunized mice, pp651-167 (c2) immunized mice, SA-
C3d (c3) immunized mice or PBS (c4) controls. Kidneys were collected at 20 weeks of age. White arrowheads indicate antibody deposition on
glomerular. dsDNA: double-stranded DNA.
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Page 11 of 15peptides [15]. In addition, a potent adjuvant that is cap-
able of eliciting strong and sustained immunity to an
antigen of low immunogenicity, such as pp65, is pre-
ferred. The C3d is an effective molecular adjuvant that
appears safe and acceptable for use in vaccines [17].
Dempsey et al. showed that C3d-conjugated hen egg
lysozyme (HEL) exhibited up to a 1,000-fold increase in
immunogenicity than HEL alone [16]. We found that
immunization of pp65336-439 peptide with C3d could
sustain the humoral immunity to pp65336-439,a n ds u c h
immunization also elicited cross-reactive antibody
against host cellular proteins, including dsDNA and its
associated proteins on non-autoimmune BALB/c mice.
T h ee t i o l o g yo fa u t o i m m u n i t yi sc o m p l e x ,e i t h e rt h e
cross-reactivity by anti-pp65336-439 antibody to multiple
nuclear components or epitope spreading by binding of
pp65 to host proteins may contribute to the out spread of
auto-reactive antibodies. We could not identify significant
sequence homology between pp65336-439 and many nuclear
targets recognized by SLE sera. Diamond et al. showed that
decapeptide DWEYSVWLSN could induce anti-dsDNA
IgG and deposition of immunoglobulin on glomeruli [28].
McClain et al. reported that the immunization with
either EBNA-1 could induced specific anti-Ro and anti-
EBNA-152-72 antibody in experimental animal, but EBNA-
152-72, with this structure, shared no amino acid sequence
homology with Ro [3]. Sunder et al. revealed that immuni-
zation of EBNA-1 not only induced anti-EBNA-1 antibody
in mice, but also exhibited cross-reactive antibodies to
both SmB/B’ and dsDNA [29]. These studies suggested
the similarity of amino acid sequence is not a requirement
for mimicry-induced autoimmunity.
Our BALB/c mice developed sustained antibodies to
pp65336-439 and nuclear components following immuni-
zation. Our immunization scheme not only sustained
the anti-pp65 activity, but also induced high titers of
Figure 7 Detection of protein-to-protein interaction between
pp65336-439 and HeLa lysate. Whole HeLa lysate was separated by
SDS-PAGE and transferred to nitrocellulose paper. The pp65336-439 or
pp651-167 His-tag fusion peptide was incubated with blot at
concentrations of 20, 10, 5, 2.5, 1.25, 0.625 mg/ml (No.1 to 6) or at
concentrations of 20, 10, 5, 2.5 mg/ml (No.7 to 10), respectively.
Asterisk indicates protein-free negative control. Molecular mass
markers (kD) are shown on the left. MW: molecular weight (kD).
Table 5 List of pp65336-439 binding proteins from yeast
two-hybrid system
Clones Binding proteins
Nuclear proteins
AD80 Thyroid hormone receptor associated protein 3
AD107 Ribosomal RNA processing 8
AD99 CAF1A chromatin assembly factor 1, subunit A
AD127 Protein DBF4 homolog A
Apoptotic related proteins
AD135 Transcriptional regulator protein (HCNGP, SAP30 BP)
AD140 YSK4 Sps1/Ste20-related kinase
AD365 Dermal papilla-derived protein 6 isoform 3
AD22 Cytochrome c oxidase subunit III
Heat shock associated protein
AD10 DnaJB3 (Hsp40)
AD87 DnaJB8 (Hsp40)
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Page 12 of 15antibodies to nuclear components, including the nucleo-
some, centriole and chromatin. Such weak anti-nuclear
responses were found on few animals never exposed to
pp65336-439. This weak anti-nuclear activity is likely due
to adjuvant-induced polyclonal activation because
neither ANA activity nor the Crithidia luciliae stain was
found from affinity-purified anti-pp651-167 antibody.
Cross-reactivity between a foreign antigen and an auto-
antigen is a characteristic of mimicry-induced autoimmu-
nity [30]. Our affinity purification results demonstrated
that the anti-pp65336-439 antibodies cross-react to several
nuclear antigens, including dsDNA, suggesting that
mimicry could play a part in the pp65-induced tolerance
break. The anti-dsDNA antibody, particularly IgG2a, was
reported to SLE nephritis and also identified from our
pp65336-439-immunized BALB/c [31,32]. Nevertheless, the
direct relation to nephritis by anti-pp65336-439 initiated
anti-dsDNA antibody of IgG2 isotype was not studied in
this work. The anti-dsDNA antibody from pp65336-439-
immunized mice was detected as early as four weeks,
suggesting that pp65336-439 is a potent inductor of cross-
reactivity. The Crithidia luciliae stain has been the
golden standard to anti-dsDNA antibody. Of 17 pp65336-
439-immunized mice, 11 and 13 mice were positive for
the Crithidia luciliae stains and ELISA assays, respec-
tively. All Crithidia luciliae-positive mouse sera also pos-
sessed high titers of anti-dsDNA activity by ELISA
assays, confirming the significant elevated anti-dsDNA
reactivity in pp65336-439-immunized animals.
The peptide-induced immunity, which cross-reacts
with both dsDNA and a-actinin, has been described and
its pathogenesis was illustrated [33]. Similar to anti-
DWEYSVWLSN antibody, affinity-purified anti-pp65336-
439 antibody from pp65336-439-immunized animals cross-
reacted with dsDNA on both Crithidia luciliae stains and
ELISA assays. Such anti-dsDNA reactivity was not found
in pp651-167 or adjuvant immunized animals. To the best
of our knowledge, HCMV has not been reported to
induce the anti-dsDNA antibody. The pathogenicity of
pp65336-439-induced anti-dsDNA antibody on BALB/c
animals was not fully examined by this study. Neverthe-
less, we found precipitation of immune complexes on
glomeruli at 12 weeks post-immunization (20 weeks of
age), and noticed positive correlation of anti-dsDNA
titers to the complex precipitation (data not shown). This
finding implies that an early stage of renal pathogenesis
that resembles SLE nephritis may have been induced by
pp65336-439-mediated cross-reactive antibody. Arbuckle et
al. have revealed that anti-dsDNA antibody could be
found as early as nine years before the diagnosis of SLE
[22]. The asymptomatic existence of anti-dsDNA activity
in our animals suggests an extended observation is
required to demonstrate the clinical consequences by
pp65 immunization. Genetics plays an essential role on
pathogenesis of autoimmunity that might also explain
the lack of clinical symptoms on our animals following
immunization [34].
In addition to mimicry, epitope spreading could be
another driving force to pp65336-439-induced autoimmu-
nity. The T-antigen of human polyomaviruses has been
shown to complex with nucleosomes of infected cells
during viral replication. These nucleosomes/T-antigen
complexes are subsequently targeted by immune
responses and become a catalyst for cross-reactive anti-
bodies against both virus and host [35]. At HCMV infec-
tion, pp65 is imported to the nucleus immediately via
two nuclear localization sequences: pp65418-438 and
pp65537-561 [36]. The pp65 has been demonstrated to
bind to metaphase-arrested chromosomes in the pp65-
expressing fibroblasts during productive virus infection
[37]. These findings prompted us to hypothesize that
pp65 may not only bind to cellular proteins, but also
form immune-complexes to DNA or other nuclear com-
ponents. As expected, pp65336-439 bound multiple cellular
proteins including nucleic acid binding proteins, nuclear
proteins, apoptosis-related proteins and heat-shock pro-
teins (Table 5). It is noteworthy that nuclear proteins and
nucleic acid binding proteins are common targets to
autoimmunity, and abnormal apoptosis has been asso-
ciated with autoimmunity [38]. These findings suggest
that antigen-bound cellular proteins shared high prob-
ability of becoming immunogenic and provide a mechan-
ism for subsequent development of autoimmunity.
Therefore, binding to intracellular proteins by full-length
or fragmented pp65 may not only generate immune-
complexes (virus/host) that are subsequently targeted by
antiviral antibodies but also increase the chance of epi-
tope spreading and lead to autoimmunity in persons with
susceptible genetic backgrounds.
Conclusions
The antibody against HCMVpp65380-439 antibody is rare
in healthy populations but is a common feature among
SLE sera. Through immunization of pp65336-439 with
C3d as adjuvant, we were able to sustain the antibody
titers to pp65336-439 peptide and demonstrate cross-reac-
tivity of anti-pp65 antibody to nuclear components,
including dsDNA on BALB/c mice. Yeast two-hybrid
analysis revealed that pp65336-439 could bind to nuclear
proteins, suggesting the immune-complexes of pp65 and
nuclear proteins may be part of the trigger to autoim-
munity. Although none of the experimental animals
developed SLE-like clinicals y m p t o m ,d e p o s i t i o no f
immunoglobulin was identified from pp65336-439-immu-
nized animals at 12 weeks post-immunization. There-
fore, a sustained humoral immunity to pp65 may
present a risk to individuals with a background predis-
posed to SLE.
Hsieh et al. Arthritis Research & Therapy 2011, 13:R162
http://arthritis-research.com/content/13/5/R162
Page 13 of 15Abbreviations
ANAs: anti-nuclear antibodies; C3d: complement 3d; CFA: complete Freund’s
adjuvant; CnBr: cyanogen bromide; CTD: connective tissue disease; dsDNA:
double-stranded DNA; EBNA-1: Epstein-Barr virus nuclear antigen 1; EBV:
Epstein-Barr virus; ELISA: Enzyme Linked Immunosorbent Assay; FITC:
fluorescein isothiocyanate; HCMV: human cytomegalovirus; HEL: hen egg
lysozyme; HRP: horseradish peroxidase; IFA: incomplete Freund’s adjuvant;
MSA-I/II: mitotic spindle type I/II; OPD: o-phenylenediamine dihydrochloride;
PBS: phosphate-buffered saline; pp65: phosphoprotein 65; RA: rheumatoid
arthritis; RT: room temperature; SA: streptavidin; SLE: systemic lupus
erythematosus; SmB/B’: Smith antigen B/B’; snRNP: small nuclear
ribonucleoprotein; SS: Sjögren’s syndrome; SSc: systemic sclerosis; YNB: yeast
nitrogen base.
Acknowledgements
We thank Dr. YL Juang for technical suggestions. The yeast strains and the
related materials in the yeast two-hybrid experiment were supported by Dr.
YL Juang. This work was undertaken at Tzu-Chi University and supported by
Grant TCIRP 95002-03 from Tzu-Chi University.
Author details
1Institute of Medical Science, Tzu-Chi University, No. 701, Sec. 3, Zhongyang
Rd., Hualien City, Hualien County 970, Taiwan.
2Institute of Microbiology
Immunology and Biochemistry, Tzu-Chi University, No. 701, Sec. 3,
Zhongyang Rd., Hualien City, Hualien County 970, Taiwan.
3The National
Laboratory Animal Center (NLAC), No. 128, Sec. 2, Academia Rd., Nangang
Dist., Taipei City 115, Taiwan.
4Development Center of Biotechnology,
No.101, Ln. 169, Kangning St., Xizhi Dist, New Taipei City 221, Taiwan.
Authors’ contributions
MC, SLW and AHH jointly contributed to the design of the study. AHH
performed ELISA, Western blot and immunofluorescence. YJJ carried out the
yeast two-hybrid. CTL participated in the tissue stains. AHH, MC and SLW
were responsible for data analysis and interpretations. AHH and MC wrote
the manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 23 March 2011 Revised: 6 September 2011
Accepted: 11 October 2011 Published: 11 October 2011
References
1. Poole BD, Scofield RH, Harley JB, James JA: Epstein-Barr virus and
molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006,
39:63-70.
2. Poole BD, Gross T, Maier S, Harley JB, James JA: Lupus-like autoantibody
development in rabbits and mice after immunization with EBNA-1
fragments. J Autoimmun 2008, 31:362-371.
3. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA: Early
events in lupus humoral autoimmunity suggest initiation through
molecular mimicry. Nat Med 2005, 11:85-89.
4. Khoshnevis M, Tyring SK: Cytomegalovirus infections. Dermatol Clin 2002,
20:291-299, vii.
5. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H: Virus infection
triggers insulin-dependent diabetes mellitus in a transgenic model: role
of anti-self (virus) immune response. Cell 1991, 65:319-331.
6. Osame K, Takahashi Y, Takasawa H, Watanabe S, Kishimoto M, Yasuda K,
Kaburagi Y, Nakanishi K, Kajio H, Noda M: Rapid-onset type 1 diabetes
associated with cytomegalovirus infection and islet autoantibody
synthesis. Intern Med 2007, 46:873-877.
7. Cheng HM, Khairullah NS: Induction of antiphospholipid autoantibody
during cytomegalovirus infection. Clin Infect Dis 1997, 25:1493-1494.
8. Zhu J: Cytomegalovirus infection induces expression of 60 KD/Ro
antigen on human keratinocytes. Lupus 1995, 4:396-406.
9. Newkirk MM, van Venrooij WJ, Marshall GS: Autoimmune response to U1
small nuclear ribonucleoprotein (U1 snRNP) associated with
cytomegalovirus infection. Arthritis Res 2001, 3:253-258.
10. Curtis HA, Singh T, Newkirk MM: Recombinant cytomegalovirus
glycoprotein gB (UL55) induces an autoantibody response to the U1-70
kDa small nuclear ribonucleoprotein. Eur J Immunol 1999, 29:3643-3653.
11. McLaughlin-Taylor E, Pande H, Forman SJ, Tanamachi B, Li CR, Zaia JA,
Greenberg PD, Riddell SR: Identification of the major late human
cytomegalovirus matrix protein pp65 as a target antigen for CD8
+ virus-
specific cytotoxic T lymphocytes. J Med Virol 1994, 43:103-110.
12. Tanaka N, Kimura H, Hoshino Y, Nishikawa K, Kojima S, Nishiyama Y,
Morishima T: Expression of tegument protein pp65 of human
cytomegalovirus (CMV) and its application to the analysis of viral-
specific cellular immunity in CMV-infected individuals. Arch Virol 2002,
147:2405-2417.
13. Khattab BA, Lindenmaier W, Frank R, Link H: Three T-cell epitopes within
the C-terminal 265 amino acids of the matrix protein pp65 of human
cytomegalovirus recognized by human lymphocytes. J Med Virol 1997,
52:68-76.
14. Kondo E, Akatsuka Y, Kuzushima K, Tsujimura K, Asakura S, Tajima K,
Kagami Y, Kodera Y, Tanimoto M, Morishima Y, Takahashi T: Identification
of novel CTL epitopes of CMV-pp65 presented by a variety of HLA
alleles. Blood 2004, 103:630-638.
15. Chang M, Pan MR, Chen DY, Lan JL: Human cytomegalovirus pp65 lower
matrix protein: a humoral immunogen for systemic lupus erythematosus
patients and autoantibody accelerator for NZB/W F1 mice. Clin Exp
Immunol 2006, 143:167-179.
16. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT: C3d of
complement as a molecular adjuvant: bridging innate and acquired
immunity. Science 1996, 271:348-350.
17. Green TD, Montefiori DC, Ross TM: Enhancement of antibodies to the
human immunodeficiency virus type 1 envelope by using the molecular
adjuvant C3d. J Virol 2003, 77:2046-2055.
18. Yu M, Li da J, Wang XL, Yuan MM, Zhu Y, Yao XY, Li HP: [Molecular
adjuvant C3d up-regulates both B7-1 and B7-2 expression on Raji cells].
Fen Zi Xi Bao Sheng Wu Xue Bao 2006, 39:77-82.
19. Olmsted JB: Affinity purification of antibodies from diazotized paper
blots of heterogeneous protein samples. J Biol Chem 1981,
256:11955-11957.
20. Linnik MD, Hu JZ, Heilbrunn KR, Strand V, Hurley FL, Joh T: Relationship
between anti-double-stranded DNA antibodies and exacerbation of
renal disease in patients with systemic lupus erythematosus. Arthritis
Rheum 2005, 52:1129-1137.
21. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB:
Development of anti-dsDNA autoantibodies prior to clinical diagnosis of
systemic lupus erythematosus. Scand J Immunol 2001, 54:211-219.
22. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA,
Harley JB: Development of autoantibodies before the clinical onset of
systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
23. Bijl M, Dijstelbloem HM, Oost WW, Bootsma H, Derksen RH, Aten J,
Limburg PC, Kallenberg CG: IgG subclass distribution of autoantibodies
differs between renal and extra-renal relapses in patients with systemic
lupus erythematosus. Rheumatology (Oxford) 2002, 41:62-67.
24. Hurd ER, Ziff M: Quantitative studies of immunoglobulin deposition in
the kidney, glomerular cell proliferation and glomerulosclerosis in NZB/
NZW F1 hybrid mice. Clin Exp Immunol 1977, 27:261-268.
25. Cui Z, Zhang K, Zhang Z, Liu Y, Zhou Y, Wei H, Zhang XE: Visualization of
the dynamic multimerization of human Cytomegalovirus pp65 in
punctuate nuclear foci. Virology 2009, 392:169-177.
26. Provenzano M, Sais G, Bracci L, Egli A, Anselmi M, Viehl CT, Schaub S,
Hirsch HH, Stroncek DF, Marincola FM, Spagnoli GC: A HCMV pp65
polypeptide promotes the expansion of CD4
+ and CD8
+ T cells across a
wide range of HLA specificities. J Cell Mol Med 2009, 13:2131-2147.
27. Landini MP, Lazzarotto T, Xu J, Geballe AP, Mocarski ES: Humoral immune
response to proteins of human cytomegalovirus latency-associated
transcripts. Biol Blood Marrow Transplant 2000, 6:100-108.
28. Putterman C, Diamond B: Immunization with a peptide surrogate for
double-stranded DNA (dsDNA) induces autoantibody production and
renal immunoglobulin deposition. J Exp Med 1998, 188:29-38.
29. Sundar K, Jacques S, Gottlieb P, Villars R, Benito ME, Taylor DK, Spatz LA:
Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the
mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. J
Autoimmun 2004, 23:127-140.
30. Deshmukh US, Kannapell CC, Fu SM: Immune responses to small nuclear
ribonucleoproteins: antigen-dependent distinct B cell epitope spreading
patterns in mice immunized with recombinant polypeptides of small
nuclear ribonucleoproteins. J Immunol 2002, 168:5326-5332.
Hsieh et al. Arthritis Research & Therapy 2011, 13:R162
http://arthritis-research.com/content/13/5/R162
Page 14 of 1531. Garcia CO, Molina JF, Gutierrez-Urena S, Scopelitis E, Wilson WA, Gharavi AE,
Espinoza LR: Autoantibody profile in African-American patients with
lupus nephritis. Lupus 1996, 5:602-605.
32. Winkler TH, Henschel TA, Kalies I, Baenkler HW, Skvaril F, Kalden JR:
Constant isotype pattern of anti-dsDNA antibodies in patients with
systemic lupus erythematosus. Clin Exp Immunol 1988, 72:434-439.
33. Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P,
Putterman C: Cross-reactivity of human lupus anti-DNA antibodies with
alpha-actinin and nephritogenic potential. Arthritis Rheum 2005,
52:522-530.
34. Mendlovic S, Brocke S, Fricke H, Shoenfeld Y, Bakimer R, Mozes E: The
genetic regulation of the induction of experimental SLE. Immunology
1990, 69:228-236.
35. Andreassen K, Bredholt G, Moens U, Bendiksen S, Kauric G, Rekvig OP: T cell
lines specific for polyomavirus T-antigen recognize T-antigen complexed
with nucleosomes: a molecular basis for anti-DNA antibody production.
Eur J Immunol 1999, 29:2715-2728.
36. Schmolke S, Drescher P, Jahn G, Plachter B: Nuclear targeting of the
tegument protein pp65 (UL83) of human cytomegalovirus: an unusual
bipartite nuclear localization signal functions with other portions of the
protein to mediate its efficient nuclear transport. J Virol 1995,
69:1071-1078.
37. Dal Monte P, Bessia C, Landini MP, Michelson S: Expression of human
cytomegalovirus ppUL83 (pp65) in a stable cell line and its association
with metaphase chromosomes. J Gen Virol 1996, 77:2591-2596.
38. Maniati E, Potter P, Rogers NJ, Morley BJ: Control of apoptosis in
autoimmunity. J Pathol 2008, 214:190-198.
doi:10.1186/ar3481
Cite this article as: Hsieh et al.: Fragment of tegument protein pp65 of
human cytomegalovirus induces autoantibodies in BALB/c mice. Arthritis
Research & Therapy 2011 13:R162.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Hsieh et al. Arthritis Research & Therapy 2011, 13:R162
http://arthritis-research.com/content/13/5/R162
Page 15 of 15